Parathyroid hormone-eluting bead - CellMed

Drug Profile

Parathyroid hormone-eluting bead - CellMed

Alternative Names: CellBead-PTH; PTH-eluting bead

Latest Information Update: 10 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CellMed
  • Class Calcium regulators; Osteoporosis therapies; Peptide hormones
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypoparathyroidism

Most Recent Events

  • 10 Aug 2007 Discontinued - Phase-II for Hypoparathyroidism in Germany (Intralesional)
  • 15 Nov 2005 Phase-II clinical trials in Hypoparathyroidism in Germany (Intralesional)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top